RT Journal Article
SR Electronic
T1 COVID-19 Outbreaks in Refugee Camps
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.02.20204818
DO 10.1101/2020.10.02.20204818
A1 Carlos Hernandez-Suarez
A1 Paolo Verme
A1 Sergiy Radyakin
A1 Efren-Murillo
YR 2020
UL http://medrxiv.org/content/early/2020/10/05/2020.10.02.20204818.abstract
AB We built a mathematical model for SARS-CoV-2 transmission and analyze it using both a deterministic and a stochastic approach. We used this model to project the burden of the disease in refugee camps characterized by peculiar demographic characteristics and a high level of deprivation, including lack of medical facilities and personnel, as well as limited possibility to implement containment and quarantine measures. Most of the parameters in our model were adapted from published literature but we used our own estimates of the basic reproduction number, R0 as well as the lethality by age group and gender. We projected the burden in terms of number of infections, number of deaths and number of bed-days in hospitalization and intensive care, among others. We conclude that the harsh conditions of refugee camps combined with a high share of young people leads to a relatively mild scenario for the burden of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe report is part of the DFID-UNHCR-World Bank program "Building the Evidence on Protracted Forced Displacement: A Multi-Stakeholder Partnership". The program is funded by UK aid from the United Kingdom's Department for International Development (DFID), it is managed by the World Bank Group (WBG) and was established in partnership with the United Nations High Commissioner for Refugees (UNHCR). The scope of the program is to expand the global knowledge on forced displacement by funding quality research and disseminating results for the use of practitioners and policy makers.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight approval requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data available https://bit.ly/3jdtOXX